Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
Top Cited Papers
- 25 August 2006
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 313 (5790) , 1137-1140
- https://doi.org/10.1126/science.1128294
Abstract
Endoplasmic reticulum (ER) stress is a key link between obesity, insulin resistance, and type 2 diabetes. Here, we provide evidence that this mechanistic link can be exploited for therapeutic purposes with orally active chemical chaperones. 4-Phenyl butyric acid and taurine-conjugated ursodeoxycholic acid alleviated ER stress in cells and whole animals. Treatment of obese and diabetic mice with these compounds resulted in normalization of hyperglycemia, restoration of systemic insulin sensitivity, resolution of fatty liver disease, and enhancement of insulin action in liver, muscle, and adipose tissues. Our results demonstrate that chemical chaperones enhance the adaptive capacity of the ER and act as potent antidiabetic modalities with potential application in the treatment of type 2 diabetes.Keywords
This publication has 16 references indexed in Scilit:
- Primary Biliary CirrhosisNew England Journal of Medicine, 2005
- Genetic epidemiology of diabetesJournal of Clinical Investigation, 2005
- The Endoplasmic Reticulum Chaperone Improves Insulin Resistance in Type 2 DiabetesDiabetes, 2005
- Involvement of Endoplasmic Reticulum Stress in Insulin Resistance and DiabetesJournal of Biological Chemistry, 2005
- Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 DiabetesScience, 2004
- XBP1, Downstream of Blimp-1, Expands the Secretory Apparatus and Other Organelles, and Increases Protein Synthesis in Plasma Cell DifferentiationPublished by Elsevier ,2004
- Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activationHepatology, 2002
- Chemical chaperones mediate increased secretion of mutant α1-antitrypsin (α1-AT) Z: A potential pharmacological strategy for prevention of liver injury and emphysema in α1-AT deficiencyProceedings of the National Academy of Sciences, 2000
- Ten–Year Survival in Ursodeoxycholic Acid-Treated Patients With Primary Biliary CirrhosisHepatology, 1999
- Long-Term Treatment of Girls with Ornithine Transcarbamylase DeficiencyNew England Journal of Medicine, 1996